Myriad Genetics Inc
MYGN- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000899923
No open-market purchases or sales by Myriad Genetics Inc insiders were filed in the last 90 days; 196 institutions reported holding it in 13F filings for Q2 2026, worth $507.8M in total; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding Myriad Genetics Inc changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Of which not filed for Q1 2022 | Q1 2022 | Change |
|---|---|---|---|---|
| Holders | 197 | 1 | 205 | +9 |
| Shares | 78.3M | 100 | 78.9M | +584.0K (+0.7%) |
| Value | $2.16B | $3.00K | $1.99B | −$172.5M (−8.0%) |
1 institution that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (31)
Institutions that held Myriad Genetics Inc at the end of Q1 2022 but not at the end of Q4 2021.
Sold out (22)
Institutions that held Myriad Genetics Inc at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Tieton Capital Management, LLC | 118,456 | $3.27M |
| Connectus Wealth, LLC | 84,754 | $2.34M |
| Duality Advisers, LP | 42,740 | $1.18M |
| CSM Advisors, LLC | 17,530 | $484.0K |
| Allstate Corp | 16,416 | $453.0K |
| S&T Bank | 14,967 | $413.0K |
| Natixis | 13,450 | $371.0K |
| Parallax Volatility Advisers, L.P. | 8,008 | $221.0K |
| Crossmark Global Holdings, Inc. | 7,590 | $209.0K |
| Chicago Trust Co NA | 7,500 | $207.0K |
| Vident Investment Advisory, LLC | 7,374 | $204.0K |
| Simplex Trading, LLC | 4,782 | $131.0K |
| Spire Wealth Management | 1,740 | $48.0K |
| KBC Group NV | 1,153 | $32.0K |
| Eaton Vance Management | 958 | $26.0K |
| Patriot Financial Group Insurance Agency, LLC | 400 | $11.0K |
| BDO Wealth Advisors, LLC | 300 | $8.00K |
| PSI Advisors, LLC | 250 | $7.00K |
| Cambridge Trust Co | 155 | $4.00K |
| Sageworth Trust Co | 69 | $2.00K |
| Bedel Financial Consulting, Inc. | 22 | $1.00K |
| Sofos Investments, Inc. | 616 | – |
Not filed for Q1 2022 yet (1)
Institutions that held Myriad Genetics Inc at the end of Q4 2021 and haven't filed a 13F for Q1 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| NEXT Financial Group, Inc | 100 | $3.00K |